tiprankstipranks
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
US Market

Stoke Therapeutics (STOK) Income Statement

Compare
374 Followers

Stoke Therapeutics Income Statement

Last quarter (Q4 2024), Stoke Therapeutics's total revenue was $22.61M, an increase of 707.07% from the same quarter last year. In Q4, Stoke Therapeutics's net income was $-10.48M. See Stoke Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 36.55M$ 8.78M$ 12.40M$ 0.00$ 0.00
Gross Profit
$ 36.55M$ 8.78M$ 8.87M$ -2.23M$ -1.93M
Operating Expenses
$ 137.93M$ 123.55M$ 116.76M$ 86.06M$ 53.04M
Depreciation and Amortization
$ 0.00$ 2.47M$ 3.54M$ 2.23M$ 1.93M
EBITDA
$ -101.37M$ -112.30M$ -102.81M$ -83.58M$ -50.32M
Operating Income
$ -101.37M$ -114.77M$ -104.36M$ -86.06M$ -53.04M
Other Income/Expenses
$ 12.39M$ 10.07M$ 3.29M$ 260.00K$ 801.00K
Pretax Income
$ -88.98M$ -104.70M$ -101.07M$ -85.81M$ -52.24M
Net Income
$ -88.98M$ -104.70M$ -93.11M$ -84.71M$ -50.61M
Per Share Metrics
Basic EPS
$ -1.65$ -2.38$ -2.39$ -2.31$ -1.51
Diluted EPS
$ -1.65$ -2.38$ -2.39$ -2.31$ -1.51
Weighted Average Shares Outstanding
54.01M 43.99M 38.90M 36.74M 33.49M
Weighted Average Shares Outstanding (Diluted)
54.01M 43.99M 38.90M 36.74M 33.49M
Currency in USD

Stoke Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis